Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian S Stevens

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Virology|August 8, 2021
Proteases and variants: context matters for SARS-CoV-2 entry assaysChristian S Stevens, Kasopefoluwa Y Oguntuyo, Benhur Lee
The Journal of General Virology|July 15, 2025
Precision engineering of human cytomegalovirus without BAC constraints: a Sendai virus-delivered CRISPR/Cas9 approachJillian C Carmichael, Christian S Stevens, Kristina E Atanasoff, et al.
The Journal of Infectious Diseases|March 4, 2023
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset ModelChristian S Stevens, Jake Lowry, Terry Juelich, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Paramyxovirus matrix proteins modulate host cell translation via exon-junction complex interactions in the cytoplasmChuan-Tien Hung, Griffin D Haas, Ruth E Watkinson, et al.
Journal of Virology|March 1, 2024
Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopesKasopefoluwa Y Oguntuyo, Griffin D Haas, Kristopher D Azarm, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cellsChristian S Stevens, Jillian Carmichael, Ruth Watkinson, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodiesKristina E Atanasoff, Luca Brambilla, Daniel C Adelsberg, et al.
Journal of Virology|November 4, 2024
A temperature-sensitive and less immunogenic Sendai virus for efficient gene editingChristian S Stevens, Jillian C Carmichael, Ruth Watkinson, et al.
Nature Communications|July 27, 2021
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variantsSatoshi Ikegame, Mohammed N A Siddiquey, Chuan-Tien Hung, et al.
Mbio|December 6, 2023
An <i>in vitro</i> experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibodyKristina E Atanasoff, Luca Brambilla, Daniel C Adelsberg, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Virology|August 8, 2021
Proteases and variants: context matters for SARS-CoV-2 entry assaysChristian S Stevens, Kasopefoluwa Y Oguntuyo, Benhur Lee
The Journal of General Virology|July 15, 2025
Precision engineering of human cytomegalovirus without BAC constraints: a Sendai virus-delivered CRISPR/Cas9 approachJillian C Carmichael, Christian S Stevens, Kristina E Atanasoff, et al.
The Journal of Infectious Diseases|March 4, 2023
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset ModelChristian S Stevens, Jake Lowry, Terry Juelich, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Paramyxovirus matrix proteins modulate host cell translation via exon-junction complex interactions in the cytoplasmChuan-Tien Hung, Griffin D Haas, Ruth E Watkinson, et al.
Journal of Virology|March 1, 2024
Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopesKasopefoluwa Y Oguntuyo, Griffin D Haas, Kristopher D Azarm, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cellsChristian S Stevens, Jillian Carmichael, Ruth Watkinson, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
An <i>in vitro</i> experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodiesKristina E Atanasoff, Luca Brambilla, Daniel C Adelsberg, et al.
Journal of Virology|November 4, 2024
A temperature-sensitive and less immunogenic Sendai virus for efficient gene editingChristian S Stevens, Jillian C Carmichael, Ruth Watkinson, et al.
Nature Communications|July 27, 2021
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variantsSatoshi Ikegame, Mohammed N A Siddiquey, Chuan-Tien Hung, et al.
Mbio|December 6, 2023
An <i>in vitro</i> experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibodyKristina E Atanasoff, Luca Brambilla, Daniel C Adelsberg, et al.
Pageof 2